British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009

Br J Dermatol. 2009 Nov;161(5):987-1019. doi: 10.1111/j.1365-2133.2009.09505.x.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Biological Therapy / methods
  • Child
  • Child, Preschool
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / therapeutic use*
  • Dermatology / methods
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Pregnancy
  • Psoriasis / complications
  • Psoriasis / therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Virus Diseases / complications
  • Virus Diseases / drug therapy

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha